Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 137.593 | 79 |
GSM780708 | Untreated after 4 days (C2_1) | 126.812 | 78 |
GSM780709 | Untreated after 4 days (C3_1) | 155.792 | 81 |
GSM780719 | Untreated after 4 days (C1_2) | 143.816 | 80 |
GSM780720 | Untreated after 4 days (C2_2) | 120.089 | 78 |
GSM780721 | Untreated after 4 days (C3_2) | 177.779 | 82 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 107.903 | 76 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 141.192 | 80 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 99.7252 | 75 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 128.202 | 79 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 139.218 | 80 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 120.418 | 78 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 174.816 | 82 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 103.557 | 76 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 153.059 | 81 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 216.137 | 84 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 135.888 | 79 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 149.201 | 80 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 139.631 | 80 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 130.438 | 79 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 125.934 | 78 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 131.027 | 79 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 137.609 | 79 |